CWST Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Casella Waste Systems is not a strong buy right now for a beginner long-term investor who wants to put money to work immediately. The stock has solid long-term business quality and analysts remain constructive, but the current setup is not compelling enough to justify an aggressive buy at this exact price. I would wait for a better entry rather than chase it today.
CWST is in a short-term bullish to improving trend. MACD histogram is positive and expanding, which supports upward momentum. However, RSI_6 at 75.414 suggests the stock is extended near overbought conditions, and the moving averages are converging rather than showing a clean breakout structure. Price is trading near resistance at 96.44 and below the next resistance at 99.569, with pivot support at 91.377. The technical picture is constructive, but not an ideal beginner entry after a recent move up.
No news in the recent week, so there are no fresh event-driven catalysts. Positives are mainly fundamentals-and-consensus based: Barclays upgraded the stock to Overweight, Goldman Sachs added it to the US Conviction List, and UBS still keeps a Buy rating. Analysts see continued EBITDA growth supported by pricing and margin improvement. Hedge fund and insider activity are neutral, so there is no strong institutional selling pressure.
The recent analyst target move from UBS was a cut from $130 to $122, which slightly tempers enthusiasm. There is no recent news flow to create a near-term catalyst, and technicals show the stock may be extended after the recent gain. Also, the stock trend model suggests limited short-term upside, with a slightly negative expected move over the next month.
No usable latest-quarter financial snapshot was provided because of a data error, so I cannot assess the most recent quarter in detail. From the analyst commentary, the latest quarter appears to have been solid enough to support upgrades and maintained Buy/Overweight ratings, with expectations for mid-single-digit EBITDA growth, synergy benefits, and margin improvement.
Wall Street remains positive overall. UBS lowered its target to $122 from $130 but kept Buy. Goldman Sachs placed CWST on its US Conviction List with a Buy rating and $120 target, highlighting sustained EBITDA growth potential. Barclays upgraded the stock to Overweight with a $102 target, citing strong Q1 results, synergy visibility, and margin inflection potential. The pros view is constructive on growth, pricing power, and margin expansion; the main con is that some upside has likely already been reflected in the price.
